{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T19:39:39Z","timestamp":1785008379655,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ejphar.2025.177557","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T03:06:24Z","timestamp":1742958384000},"page":"177557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Discovery of the first isoform-specific sGC activator: Selective activation of GC-1 by runcaciguat"],"prefix":"10.1016","volume":"996","author":[{"given":"Svenja","family":"Stomberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0481-6221","authenticated-orcid":false,"given":"Anne","family":"R\u00fchle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0911-4376","authenticated-orcid":false,"given":"Theresa","family":"Wittrien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2977-7553","authenticated-orcid":false,"given":"Peter","family":"Sandner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9068-0729","authenticated-orcid":false,"given":"S\u00f6nke","family":"Behrends","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejphar.2025.177557_bib1","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1073\/pnas.97.6.2928","article-title":"Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses","volume":"97","author":"Bellamy","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"17","key":"10.1016\/j.ejphar.2025.177557_bib2","article-title":"The sGC activator runcaciguat has kidney protective effects and Prevents a decline of kidney function in ZSF1 rats","volume":"24","author":"Benardeau","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177557_bib3","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1124\/jpet.115.230706","article-title":"A soluble guanylate cyclase activator inhibits the progression of diabetic nephropathy in the ZSF1 rat","volume":"356","author":"Boustany-Kari","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177557_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1124\/jpet.115.227728","article-title":"Angiotensin II-induced hypertension is attenuated by reduction of sympathetic output in NO-sensitive guanylyl cyclase 1 knockout mice","volume":"356","author":"Broekmans","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177557_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0006-291X(91)90527-E","article-title":"Expression of soluble guanylate cyclase activity requires both enzyme subunits","volume":"174","author":"Buechler","year":"1991","journal-title":"BBRC (Biochem. Biophys. Res. Commun.)"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177557_bib6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1074\/jbc.M113.504472","article-title":"Nitric oxide activation of guanylate cyclase pushes the \u03b11 signaling helix and the \u03b21 heme-binding domain closer to the substrate-binding site","volume":"289","author":"Busker","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"gfae261","key":"10.1016\/j.ejphar.2025.177557_bib7","article-title":"The soluble guanylate cyclase activator runcaciguat significantly improves albuminuria in patients with chronic kidney disease: a randomized placebo-controlled clinical trial","author":"Gansevoort","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"issue":"9","key":"10.1016\/j.ejphar.2025.177557_bib8","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/eurjhf\/hfs093","article-title":"Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes","volume":"14","author":"Gheorghiade","year":"2012","journal-title":"Eur. J. Heart Fail."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177557_bib9","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1460-9568.2001.01421.x","article-title":"Subunits of the nitric oxide receptor, soluble guanylyl cyclase, expressed in rat brain","volume":"13","author":"Gibb","year":"2001","journal-title":"Eur. J. Neurosci."},{"issue":"11","key":"10.1016\/j.ejphar.2025.177557_bib10","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.bcp.2010.08.007","article-title":"Direct fusion of subunits of heterodimeric nitric oxide sensitive guanylyl cyclase leads to functional enzymes with preserved biochemical properties: evidence for isoform specific activation by ciguates","volume":"80","author":"Haase","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177557_bib11","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1471-4159.2009.06484.x","article-title":"Nitric oxide sensitive guanylyl cyclase activity decreases during cerebral postnatal development because of a reduction in heterodimerization","volume":"112","author":"Haase","year":"2010","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177557_bib12","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1523\/JNEUROSCI.4706-06.2007","article-title":"Long-term potentiation in the visual cortex requires both nitric oxide receptor guanylyl cyclases","volume":"27","author":"Haghikia","year":"2007","journal-title":"The Journal of neuroscience the official journal of the Society for Neuroscience"},{"issue":"9","key":"10.1016\/j.ejphar.2025.177557_bib13","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1021\/acs.jmedchem.0c02154","article-title":"Discovery of the soluble guanylate cyclase activator runcaciguat (BAY 1101042)","volume":"64","author":"Hahn","year":"2021","journal-title":"J. Med. Chem."},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2025.177557_bib14","first-page":"217","article-title":"Molecular cloning and expression of a new alpha-subunit of soluble guanylyl cyclase. Interchangeability of the alpha-subunits of the enzyme","volume":"292","author":"Harteneck","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2025.177557_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bcp.2016.10.008","article-title":"Heterodimerization with the \u03b21 subunit directs the \u03b12 subunit of nitric oxide-sensitive guanylyl cyclase to calcium-insensitive cell-cell contacts in HEK293 cells: interaction with Lin7a","volume":"122","author":"Hochheiser","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.ejphar.2025.177557_bib16","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.5012\/bkcs.2002.23.11.1511","article-title":"High sensitive and fast protein detection with Coomassie brilliant Blue in sodium dodecyl sulfate-polyacrylamide gel electrophoresis","volume":"23","author":"Kang","year":"2002","journal-title":"Bull. Kor. Chem. Soc."},{"issue":"7777","key":"10.1016\/j.ejphar.2025.177557_bib17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41586-019-1584-6","article-title":"Structural insights into the mechanism of human soluble guanylate cyclase","volume":"574","author":"Kang","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177557_bib18","first-page":"71","article-title":"Nitric oxide-independent activation of soluble nitric oxide-indipendent activation of soluble guanylate cyclase by BAY 60-2770 in experimental liver fibrosis","volume":"58","author":"Knorr","year":"2008","journal-title":"Arzneimittel-Forschung (Drug Research)"},{"issue":"19","key":"10.1016\/j.ejphar.2025.177557_bib19","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1006\/meth.1999.0891","article-title":"Studying the structure and regulation of soluble guanylyl cyclase","author":"Koesling","year":"1999","journal-title":"Methods"},{"key":"10.1016\/j.ejphar.2025.177557_bib20","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0167-4781(00)00211-6","article-title":"Cloning and functional expression of the rat a2 subunit of soluble guanylyl cyclase1","author":"Koglin","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"17","key":"10.1016\/j.ejphar.2025.177557_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713226","article-title":"The sGC activator runcaciguat has kidney protective effects and prevents a decline of kidney function in ZSF1 rats","volume":"24","author":"Kraehling","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ejphar.2025.177557_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025772","article-title":"The amino-terminus of nitric oxide sensitive guanylyl cyclase \u03b11 does not affect dimerization but influences subcellular localization","volume":"6","author":"Kraehling","year":"2011","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.ejphar.2025.177557_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0898-6568(02)00078-5","article-title":"Major occurrence of the new alpha2beta1 isoform of NO-sensitive guanylyl cyclase in brain","author":"Mergia","year":"2003","journal-title":"Cell. Signal."},{"issue":"8","key":"10.1016\/j.ejphar.2025.177557_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082313","article-title":"cGMP imaging in brain slices reveals brain region-specific activity of NO-sensitive guanylyl cyclases (NO-GCs) and NO-GC stimulators","volume":"19","author":"Peters","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177557_bib25","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/j.pain.0000000000001440","article-title":"Distinct functions of soluble guanylyl cyclase isoforms NO-GC1 and NO-GC2 in inflammatory and neuropathic pain processing","volume":"160","author":"Petersen","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2025.177557_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173203","article-title":"Tyrosine 135 of the \u03b21 subunit as binding site of BAY-543: importance of the Y-x-S-x-R motif for binding and activation by sGC activator drugs","volume":"881","author":"R\u00fchle","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177557_bib27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1042\/bj3350125","article-title":"Functional properties of a naturally occurring isoform of soluble guanylyl cyclase","volume":"335","author":"Russwurm","year":"1998","journal-title":"Biochem. J."},{"issue":"48","key":"10.1016\/j.ejphar.2025.177557_bib28","doi-asserted-by":"crossref","first-page":"44647","DOI":"10.1074\/jbc.M105587200","article-title":"Guanylyl cyclase\/PSD-95 interaction: targeting of the nitric oxide-sensitive alpha2beta1 guanylyl cyclase to synaptic membranes","volume":"276","author":"Russwurm","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177557_bib29","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1074\/jbc.M310141200","article-title":"Identification of residues crucially involved in the binding of the heme moiety of soluble guanylate cyclase","volume":"279","author":"Schmidt","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.177557_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bcp.2017.11.010","article-title":"BAY 60-2770 activates two isoforms of nitric oxide sensitive guanylyl cyclase: evidence for stable insertion of activator drugs","volume":"147","author":"S\u00f6mmer","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"20","key":"10.1016\/j.ejphar.2025.177557_bib31","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.110.981738","article-title":"Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease","volume":"123","author":"Stasch","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2025.177557_bib32","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/sj.bjp.0704778","article-title":"NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle","volume":"136","author":"Stasch","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.ejphar.2025.177557_bib33","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1111\/bph.15586","article-title":"Novel soluble guanylyl cyclase activators increase glomerular cGMP, induce vasodilation and improve blood flow in the murine kidney","volume":"179","author":"Stehle","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177557_bib34","doi-asserted-by":"crossref","first-page":"L450","DOI":"10.1152\/ajplung.00404.2021","article-title":"The differential roles of the two NO-GC isoforms in adjusting airway reactivity","volume":"323","author":"Verheyen","year":"2022","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ejphar.2025.177557_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116739","article-title":"Runcaciguat activates soluble guanylyl cyclase via the histidine essential for heme binding and nitric oxide activation","volume":"232","author":"Wittrien","year":"2025","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177557_bib36","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/ejendo\/lvae030","article-title":"Heterozygous gain of function variant in GUCY1A2 may cause autonomous ovarian hyperfunction","volume":"190","author":"Wittrien","year":"2024","journal-title":"Eur. J. Endocrinol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925003115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925003115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T14:24:26Z","timestamp":1745072666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925003115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":36,"alternative-id":["S0014299925003115"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177557","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of the first isoform-specific sGC activator: Selective activation of GC-1 by runcaciguat","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177557","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"177557"}}